Manchester Financial’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Manchester Financial’s Portfolio GRTX Stock Details GRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-72,000	Closed	-$10.1K	–	114
2024 Q1	$10.1K	Buy	72,000 +50,000	+227%	+$9.85K	﹤0.01%	98
2023 Q4	$3.2K	Sell	22,000 -27,900	-56%	-$4.33K	﹤0.01%	94
2023 Q3	$8.74K	Buy	+49,900	New	+$62K	﹤0.01%	94

Other funds holding GRTX

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Manchester Financial's GRTX Position: Q2 2024 in Review

Manchester Financial sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q2 2024, closing a stake of 72,000 shares — an estimated $10.1K sold.

Manchester Financial first reported a position in GRTX in Q3 2023 and held it in 3 quarters. The position peaked at $10.1K in Q1 2024. 1 fund tracked by Wall St. Rank holds GRTX as of Q2 2024.

Manchester Financial reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Manchester Financial sold 72,000 Galera Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $10.1K.
Manchester Financial first reported a position in Galera Therapeutics, Inc. Common Stock in Q3 2023 and held it in 3 quarters.
Manchester Financial's Galera Therapeutics, Inc. Common Stock position peaked at $10.1K in Q1 2024.
1 fund tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q2 2024.

Based on Manchester Financial's 13F filing for Q2 2024, filed 17 Jul 2024.